We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$361M
AUM Growth
+$61M
Cap. Flow
+$17.1M
Cap. Flow %
4.75%
Top 10 Hldgs %
25.92%
Holding
346
New
32
Increased
163
Reduced
43
Closed
36

Top Sells

Rank Stock Value
1
CMA
Comerica
CMA
+$5.93M
2
MSFT icon
Microsoft
MSFT
+$5.32M
3
EQR icon
Equity Residential
EQR
+$5.24M
4
BKR icon
Baker Hughes
BKR
+$4.61M
5
SEE
Sealed Air
SEE
+$618K

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Consumer Staples 15.06%
3 Energy 14.25%
4 Financials 13.67%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDOS icon
151
Leidos
LDOS
$17.5B
$330K 0.09%
3,134
+632
+25% +$64.7K
JKHY icon
152
Jack Henry & Associates
JKHY
$11B
$324K 0.09%
1,848
+358
+24% +$66.1K
AJRD
153
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$322K 0.09%
5,756
+878
+18% +$43.5K
EWL icon
154
iShares MSCI Switzerland ETF
EWL
$2.24B
$317K 0.09%
7,557
-87
-1% -$3.54K
EWC icon
155
iShares MSCI Canada ETF
EWC
$6.48B
$313K 0.09%
9,564
-116
-1% -$3.84K
DTE icon
156
DTE Energy
DTE
$28.8B
$312K 0.09%
2,658
+3
+0.1% +$340
MTB icon
157
M&T Bank
MTB
$36.1B
$309K 0.09%
2,133
+2
+0.1% +$329
EIS icon
158
iShares MSCI Israel ETF
EIS
$889M
$304K 0.08%
5,433
-49
-0.9% -$2.9K
AES icon
159
AES
AES
$10.5B
$302K 0.08%
+10,507
New +$283K
HRMY icon
160
Harmony Biosciences
HRMY
$2.28B
$285K 0.08%
5,164
+771
+18% +$42.4K
SNA icon
161
Snap-on
SNA
$21.3B
$283K 0.08%
+1,238
New +$280K
VCSH icon
162
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$281K 0.08%
3,743
OPCH icon
163
Option Care Health
OPCH
$3.67B
$278K 0.08%
9,242
+1,179
+15% +$36.6K
AIT icon
164
Applied Industrial Technologies
AIT
$13.3B
$276K 0.08%
2,187
+334
+18% +$41K
SCHO icon
165
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$275K 0.08%
11,390
HES
166
DELISTED
Hess
HES
$273K 0.08%
+1,922
New +$264K
ALE
167
DELISTED
Allete
ALE
$271K 0.08%
4,201
+524
+14% +$31.1K
FUL icon
168
H.B. Fuller
FUL
$3.27B
$266K 0.07%
3,709
+516
+16% +$37.3K
NBR icon
169
Nabors Industries
NBR
$1.31B
$265K 0.07%
1,708
+260
+18% +$38.8K
NOV icon
170
NOV
NOV
$7.35B
$262K 0.07%
12,524
+1,425
+13% +$29.9K
ORI icon
171
Old Republic International
ORI
$10.2B
$260K 0.07%
10,747
+1,436
+15% +$33.7K
PBH icon
172
Prestige Consumer Healthcare
PBH
$2.55B
$257K 0.07%
4,107
+572
+16% +$32.8K
FLO icon
173
Flowers Foods
FLO
$1.52B
$256K 0.07%
8,902
+1,140
+15% +$32K
IOSP icon
174
Innospec
IOSP
$2.29B
$255K 0.07%
2,476
+310
+14% +$31.5K
AVT icon
175
Avnet
AVT
$7.93B
$254K 0.07%
6,107
+795
+15% +$33.1K

Similar funds

Contravisory Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Contravisory Investment Management held 346 positions worth $361M, up 20% from $300M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management deployed $17.1M of net new capital in Q4 2022, opening 32 new positions and adding to 163 existing holdings. Its largest new stake was PepsiCo: 34,763 shares worth $6.28M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Energy.

On the sell side, the largest reduction was Comerica, an estimated $5.93M trimmed.

  • Contravisory Investment Management's largest Q4 2022 buy was PepsiCo: 34,763 shares worth $6.28M.
  • Contravisory Investment Management added most to Dollar General in Q4 2022, an estimated $6.18M increase.
  • Contravisory Investment Management's biggest Q4 2022 reduction was Comerica, cutting an estimated $5.93M.
  • Contravisory Investment Management fully exited Baker Hughes in Q4 2022, selling an estimated $4.61M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $361M portfolio in Q4 2022.
  • Contravisory Investment Management opened 32 new positions and closed 36 in Q4 2022.
  • Contravisory Investment Management's portfolio value rose 20% quarter-over-quarter to $361M.

Based on Contravisory Investment Management's 13F filing for Q4 2022, filed 13 Jan 2023.